News Details

( As on 15/11/2022 14:32)

Suven Pharmaceutical - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and half-year ended September 30, 2022 conducted after the meeting of Board of Directors held on November 8, 2022.\r\n\r\nThe above information has been uploaded on the Company's website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release\r\n\r\nThis is for your information and record.